Filing Details
- Accession Number:
- 0001140361-16-048297
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-21 10:08:40
- Reporting Period:
- 2016-01-19
- Filing Date:
- 2016-01-21
- Accepted Time:
- 2016-01-21 10:08:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
811240 | Biolase Inc | BIOL | Dental Equipment & Supplies (3843) | 870442441 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1021412 | W Jack Schuler | 100 North Field Drive Suite 360 Lake Forest IL 60045 | No | No | Yes | No | |
1661351 | Trust Living Schuler W. Jack | 100 North Field Drive Suite 360 Lake Forest IL 60045 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-01-19 | 4,300 | $0.79 | 6,428,674 | No | 4 | P | Indirect | By Trust |
Common Stock | Acquisiton | 2016-01-20 | 19,900 | $0.74 | 6,448,574 | No | 4 | P | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Trust |
No | 4 | P | Indirect | By Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 14,800 | Indirect | By spouse |
Footnotes
- These shares are held by the Jack W. Schuler Living Trust (the "Trust"). Mr. Schuler serves as sole trustee to the Trust.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7801 to $0.79, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7101 to $0.765, inclusive.